Epstein Secrets

er Could Apply For FDA's Emergency Authorization Of Vaccine As Soon As This Week. On ABC World News TonightVI (11/15, story 2, 2:15, Llamas, 4.5M), Elwyn Lopez reported Pfizer, "the first drug maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as e

ble Global Government Relations & Public Policy Associate Director Tara Hogan Charles, AstraZeneca Microbial Sciences Vice President Dr Mark Esser, McCain Institute Board of Trustees Chair Cindy McCain, former USAID COVIC-19 Task Force Executive Director Dr Ken Staley, and USGLC President and CEO Liz Schrayer; 12:00 PM • Bicamer

er Could Apply For FDA's Emergency Authorization Of Vaccine As Soon As This Week. On ABC World News TonightVI (11/15, story 2, 2:15, Llamas, 4.5M), Elwyn Lopez reported Pfizer, "the first drug maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as e

ble Global Government Relations & Public Policy Associate Director Tara Hogan Charles, AstraZeneca Microbial Sciences Vice President Dr Mark Esser, McCain Institute Board of Trustees Chair Cindy McCain, former USAID COVIC-19 Task Force Executive Director Dr Ken Staley, and USGLC President and CEO Liz Schrayer; 12:00 PM • Bicamer

er Could Apply For FDA's Emergency Authorization Of Vaccine As Soon As This Week. On ABC World News TonightVI (11/15, story 2, 2:15, Llamas, 4.5M), Elwyn Lopez reported Pfizer, "the first drug maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as e

ble Global Government Relations & Public Policy Associate Director Tara Hogan Charles, AstraZeneca Microbial Sciences Vice President Dr Mark Esser, McCain Institute Board of Trustees Chair Cindy McCain, former USAID COVIC-19 Task Force Executive Director Dr Ken Staley, and USGLC President and CEO Liz Schrayer; 12:00 PM • Bicamer